The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100. Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30. A shorter period RSI is more reactive to recent price changes, so it can show early signs of reversals. 9-Day RSI is sometimes used together with 14-Day RSI in a two period divergence strategy.
As of today (2026-07-08), Medibank Pvt's 9-Day RSI is 53.54.
The industry rank for Medibank Pvt's 9-Day RSI or its related term are showing as below:
MDBKY's 9-Day RSI is ranked worse than 54.48% of 591
companies
in the Insurance industry
Industry Median: 59.58
vs MDBKY: 53.54
Medibank Pvt (OTCPK:MDBKY) 9-Day RSI Explanation
The Relative Strength Index (RSI), developed by J. Welles Wilder in his book “New Concepts in Technical Trading Systems.”, is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100.
Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30. A RSI surpasses the 30 level indicates a bullish sign, when it slides below 70 level, it’s a bearish sign. This level can be adjusted depending on the security’s pattern and the market’s underlying trend. In an uptrend or bullish market, the RSI might range within a higher interval, investors could set the support level higher. If a downtrend or bearish market occurs, investors may need to lower the resistance level.
RSI can also be used in trading techniques to indicate the trading signal, such as Divergences and Swing Rejections. A shorter period RSI is more reactive to recent price changes, so it can show early signs of reversals. 9-Day RSI is sometimes used together with 14-Day RSI in a two period divergence strategy.
Medibank Pvt 9-Day RSI Related Terms
MDBKY vs FNF, AXS, FAF: 9-Day RSI Comparison
For the Insurance - Specialty subindustry, Medibank Pvt's 9-Day RSI, along with its competitors' market caps and 9-Day RSI data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Medibank Pvt 9-Day RSI vs Insurance Industry
For the Insurance industry and Financial Services sector, Medibank Pvt's 9-Day RSI distribution charts can be found below:
* The bar in red indicates where Medibank Pvt's 9-Day RSI falls into.
* Note that the formula uses a positive value for the average loss.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Medibank Pvt (MDBKY) has a 9-Day RSI of 53.54 as of Jul. 08, 2026. According to the industry distribution chart, Medibank Pvt ranks #322 out of 591 companies in the Insurance industry, placing it in the top 54.5%.
Is Medibank Pvt's 9-Day RSI too high?
Medibank Pvt's current 9-Day RSI is 53.54. The Insurance industry median 9-Day RSI is 59.58. Medibank Pvt's value of 53.54 is 10.1% below this industry median. Based on the distribution chart, Medibank Pvt ranks #322 out of 591 companies in the Insurance industry, which is below the industry midpoint. Overall, Medibank Pvt has a GF Score™ of 63/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Medibank Pvt's 9-Day RSI compare to FNF and AXS?
According to the Insurance industry distribution chart, Medibank Pvt ranks #322 out of 591 companies for 9-Day RSI. This places Medibank Pvt in the lower half of its industry. The industry median 9-Day RSI is 59.58. Medibank Pvt's value of 53.54 is 10.1% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 9-Day RSI for an Insurance company?
The median 9-Day RSI among Insurance companies is 59.58, based on 591 companies in the industry. Companies in the top quartile (top 25%) have a 9-Day RSI significantly above this median, while those in the bottom quartile fall well below. However, 9-Day RSI should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Medibank Pvt's current 9-Day RSI of 53.54 is 10.1% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 9-Day RSI mean?
A high 9-Day RSI can signal that a stock is expensive relative to its fundamentals. For the Insurance industry, the median 9-Day RSI is 59.58 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Medibank Pvt's current 9-Day RSI is 53.54. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medibank Pvt stock overvalued right now?
Based on GuruFocus' analysis, Medibank Pvt (MDBKY) is currently considered Significantly Overvalued. The stock's GF Value™ is $21.90, compared to a current price of $33.19 — trading 51.6% above its estimated fair value. The current 9-Day RSI is 53.54 and 10.1% below the Insurance industry median of 59.58. Medibank Pvt's overall GF Score™ is 63/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 9-Day RSI calculated?
9-Day RSI is calculated from a company's financial statements. For Medibank Pvt (MDBKY), the current 9-Day RSI is 53.54 as of Jul. 08, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Medibank Pvt (MDBKY) Overvalued in 2026?
Based on GuruFocus' analysis, Medibank Pvt stock appears to be overvalued.
The current stock price of $33.19 is trading 51.6% above its estimated GF Value™ of $21.90.
GuruFocus considers Medibank Pvt to be Significantly Overvalued.
Key valuation signals for MDBKY:
9-Day RSI: 53.54
GF Value™: $21.90 vs. price of $33.19 (51.6% above fair value)
Industry Position: 10.1% below the Insurance median (#322 of 591)
No single metric tells the full story. See the MDBKY stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Previously owned by the Australian government, Medibank is the largest health insurer in Australia. Its two brands, Medibank Private and Ahm, cover around 5 million people. Medibank and Australia's fourth-largest health fund, NIB Holdings, are the only listed health insurers. In addition to private health insurance, the firm provides life, pet, and travel insurance, as well as health insurance for overseas students and temporary overseas workers. The Medibank Health division provides healthcare services to businesses, governments, and communities across Australia and New Zealand.
63GF Score
Get the complete analysis for MDBKY
9-Day RSI is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MDBKY has been successfully added to your 